GenTAC Alliance Clinical Science Vice Chair Sherene Shalhub continues collaborative research on Vascular EDS with support of PCORI Engagement Award!

We’re pleased to announce GenTAC Alliance Clinical Science Working Group Vice Chair, Sherene Shalhub’s receipt of two research awards.

Eugene Washington PCORI Engagement Award: Engaging Patients with Type B Aortic Dissections as Partners in Patient-Centered Outcomes Research.

With this two-year, $250,000 award, Dr. Shalhub is studying patients with type B aortic dissection (TBAD) who face complex decisions with regards to the management of their aortic dissection.  The objective of this initiative is to build a collaborative aortic dissection research infrastructure that will facilitate patient centered outcomes research training, support, and networking among patients with TBAD, surgeons, cardiologists,  researchers, industry stakeholders, and patient advocacy groups. The main outcome of this work is to assemble a broad network of patients with TBAD and stakeholders, who are well informed and who will guide the research prioritization in TBAD research.

Dr. Shalhub and her collaborators anticipate that as they work together, they will identify findings that are relevant to daily clinical practice and can be immediately adapted for wide dissemination and will identify TBAD related knowledge gaps that would benefit from patient centered outcomes research and comparative effectiveness research.  Creation of the community will also allow us to evaluate patients’ willingness to participate in future randomized TBAD related research studies which are very much needed for this disease process. 

The award time: 8/1/2019-7/31/2021

 

Vascular Ehlers-Danlos Syndrome Patient-Centered Research Conference award.

This is a one year $50,000 Eugene Washington PCORI Engagement Award that builds on the successful work of creating the Vascular Ehlers-Danlos Syndrome collaborative which was funded by the PCORI Tier A Pipeline to Proposal award in October 2017. The goal is to bring a much larger stakeholder group together (patients, advocacy organizations members, physicians, researchers, and industry) and review the questions feasibility to create feasible patient centered outcomes research (PCOR) and comparative effectives research (CER) projects eligible for funding.

This award time is 2/4/2019-2/3/2020

Website: https://www.vedscollaborative.org/

 

 

 

Update on Clinical Trials of Losartan With andWithout β-Blockers to Block Aneurysm Growth in PatientsWith Marfan Syndrome

New review by Marion A. Hofmann Bowman, MD, PhD; Kim A. Eagle, MD; Dianna M. Milewicz, MD, PhD on the the results of clinical trials using β-blocker, losartan potassium, and irbesartan in patients with Marfan syndrome and comments briefly on mechanisms of aortic remodeling, including fibrosis and transforming growth factor β signaling. 

Update on Clinical Trials JAMA Journal 5/9/19

Reflections from the ACC. 2019

Check out Dr. Kim Eagle’s presentation at American College of Cardiology Annual Scientific Sessions 2019 titled, “Acute Aortic Dissection: Lesson Learned from 9000 Patients Presentation. Dr. Eagle outlines how approaches to diagnosis, treatment, and outcomes of acute aortic dissection have changed over the last 25 years. He reflects on what we have learned and where we need to go in the next 25 years.

Lessons Learned from 9000 Patients Presentation

GenTAC Alliance Statement on Recent FDA Warning Concerning Fluoroquinolones

GenTAC Alliance Statement on Recent FDA Warning Concerning Fluoroquinolones